131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study

2015 ◽  
Vol 42 (8) ◽  
pp. 1172-1178 ◽  
Author(s):  
Kuan-Yin Ko ◽  
Chia-Hung Kao ◽  
Cheng-Li Lin ◽  
Wen-Sheng Huang ◽  
Ruoh-Fang Yen
Keyword(s):  
Cohort Study ◽  
Thyroid Cancer ◽  
Lacrimal Gland ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy ◽  
131I Treatment

Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel

Thyroid ◽  
2017 ◽  
Vol 27 (6) ◽  
pp. 793-801 ◽  
Author(s):  
Elena Izkhakov ◽  
Micha Barchana ◽  
Irena Liphshitz ◽  
Barbara G. Silverman ◽  
Naftali Stern ◽  
...  
Keyword(s):  
Cohort Study ◽  
Thyroid Cancer ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy

scholarly journals Mortality of lung cancer as a second primary malignancy: A population‐based cohort study

2019 ◽  
Vol 8 (6) ◽  
pp. 3269-3277
Author(s):  
Lei Deng ◽  
Hrönn Harðardottír ◽  
Huan Song ◽  
Zhengrui Xiao ◽  
Changchuan Jiang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy

Prognosis of lung cancer as a second primary malignancy among cancer survivors: A population-based cohort study.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e21005-e21005
Author(s):  
Lei Deng ◽  
Zhengrui Xiao ◽  
Changchuan Jiang ◽  
Qian Wang ◽  
Haiying Cheng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Cancer Survivors ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy

Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study

2018 ◽  
Vol 8 (6) ◽  
pp. 756-762 ◽  
Author(s):  
Ashwin Ganti ◽  
Max A. Plitt ◽  
Edward C. Kuan ◽  
Hannah N. Kuhar ◽  
Pete S. Batra ◽  
...  
Keyword(s):  
Cohort Study ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy

scholarly journals Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study

2015 ◽  
Vol 108 (2) ◽  
pp. djv314 ◽  
Author(s):  
Chung-Jen Teng ◽  
Yu-Wen Hu ◽  
San-Chi Chen ◽  
Chiu-Mei Yeh ◽  
Huey-Ling Chiang ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Radioactive Iodine ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy ◽  
Population Based Study

Occurrence of second primary malignancy in medullary thyroid cancer (MTC) patients

2019 ◽  
Author(s):  
George Simeakis ◽  
Katerina Saltiki ◽  
Evangelia Zapanti ◽  
Evanthia Kassis ◽  
Maria Alevizaki
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy ◽  
Medullary Thyroid

The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study

2021 ◽  
Author(s):  
Jia Hong ◽  
Rongrong Wei ◽  
Chuang Nie ◽  
Anastasiia Leonteva ◽  
Xu Han ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Cox Regression ◽  
Population Based ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Risk Models ◽  
Primary Malignancy ◽  
Population Based Study ◽  
Competing Risk Models

Aim: To assess and predict risk and prognosis of lung cancer (LC) patients with second primary malignancy (SPM). Methods: LC patients diagnosed from 1992 to 2016 were obtained through the Surveillance, Epidemiology, and End Results database. Standardized incidence ratios were calculated to evaluate SPM risk. Cox regression and competing risk models were applied to assess the factors associated with overall survival, SPM development and LC-specific survival. Nomograms were built to predict SPM probability and overall survival. Results & conclusion: LC patients remain at higher risk of SPM even though the incidence declines. Patients with SPM have a better prognosis than patients without SPM. The consistency indexes for nomograms of SPM probability and overall survival are 0.605 (95% CI: 0.598–0.611) and 0.644 (95% CI: 0.638–0.650), respectively.

Sign in / Sign up

Export Citation Format

Share Document